AIMD
AinosยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AIMD Profile
Ainos, Inc.
A healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications
8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108
--
Ainos, Inc., a Texas corporation, was founded on June 26, 1984. Ainos is a diversified medical technology company focused on the development of novel point-of-care tests (POCT), low-dose interferon therapy and synthetic RNA (SRNA) to drive preventive medicine. Since its inception, the company has focused on research into low-dose non-injectable interferon therapies. The company recently expanded its product candidates to POCT to diversify the company's revenue streams. The POCT device is based on the core technology involved in the COVID 19 POCT product and other POCT products that detect volatile organic compounds (VOCs) released by the human body.
